"Metabolic Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Descriptor ID |
D024821
|
| MeSH Number(s) |
C18.452.394.968.500.570 C18.452.625
|
| Concept/Terms |
Metabolic Syndrome- Metabolic Syndrome
- Metabolic Syndromes
- Syndrome, Metabolic
- Syndromes, Metabolic
- Metabolic Syndrome X
- Insulin Resistance Syndrome X
- Syndrome X, Metabolic
- Syndrome X, Insulin Resistance
- Metabolic X Syndrome
- Syndrome, Metabolic X
- X Syndrome, Metabolic
- Dysmetabolic Syndrome X
- Syndrome X, Dysmetabolic
- Reaven Syndrome X
- Syndrome X, Reaven
- Metabolic Cardiovascular Syndrome
- Cardiovascular Syndrome, Metabolic
- Cardiovascular Syndromes, Metabolic
- Syndrome, Metabolic Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Metabolic Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Metabolic Syndrome".
This graph shows the total number of publications written about "Metabolic Syndrome" by people in this website by year, and whether "Metabolic Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 2 | 0 | 2 |
| 2003 | 7 | 2 | 9 |
| 2004 | 7 | 2 | 9 |
| 2005 | 13 | 3 | 16 |
| 2006 | 10 | 1 | 11 |
| 2007 | 12 | 1 | 13 |
| 2008 | 10 | 5 | 15 |
| 2009 | 9 | 1 | 10 |
| 2010 | 5 | 2 | 7 |
| 2011 | 17 | 5 | 22 |
| 2012 | 12 | 6 | 18 |
| 2013 | 11 | 1 | 12 |
| 2014 | 8 | 4 | 12 |
| 2015 | 14 | 1 | 15 |
| 2016 | 7 | 4 | 11 |
| 2017 | 6 | 0 | 6 |
| 2018 | 7 | 0 | 7 |
| 2019 | 7 | 2 | 9 |
| 2020 | 8 | 4 | 12 |
| 2021 | 8 | 2 | 10 |
| 2022 | 9 | 0 | 9 |
| 2023 | 5 | 0 | 5 |
| 2024 | 6 | 1 | 7 |
| 2025 | 5 | 1 | 6 |
| 2026 | 9 | 1 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Metabolic Syndrome" by people in Profiles.
-
Polyendocrine metabolic ovarian syndrome and venous thromboembolism: Hemostatic considerations in diagnosis and management. Thromb Res. 2026 Sep; 265:109809.
-
Food Insecurity and Cardiovascular-Kidney-Metabolic Syndrome-Related Conditions Among US Adults, National Health and Nutrition Examination Survey, 2015-2020. Prev Chronic Dis. 2026 Aug 27; 23:E36.
-
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026 Jul 28; 154(4):e50-e158.
-
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2026 Aug 04; 88(5):589-612.
-
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2026 Jul 28; 154(4):e159-e180.
-
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026 Jun 09; 87(22S):e1889-e2007.
-
Fructose: metabolic signal and modern hazard. Nat Metab. 2026 May; 8(5):1019-1033.
-
C-reactive protein-triglyceride-glucose index is an independent predictor of cardiovascular mortality in patients with metabolic syndrome. J Clin Lipidol. 2026 05; 20(5):915-925.
-
Metabolic syndrome and immune-related adverse events. Cancer Immunol Immunother. 2026 Jan 27; 75(2):39.
-
Clinical outcomes in MetALD compared with ALD in patients referred for liver transplant evaluation. Hepatol Commun. 2026 Feb 01; 10(2).